A new blood test measures cell-free DNA to detect ALS early and distinguish it from other neurological disorders.

Cell-free DNA (cfDNA) has emerged as a powerful biomarker for monitoring allograft health and detecting rejection in solid ...

A heart transplant recipient safely carried a baby to term using noninvasive DNA monitoring—marking a new milestone in maternal and transplant care.

EMBL researchers created SDR-seq, a next-generation tool that decodes both DNA and RNA from the same cell. It finally opens ...

In recent years, the market size for cell-free DNA (cfDNA) kits has expanded swiftly. This market is projected to increase from $1.60 billion in 2024 to $1.80 billion in 2025, marking a compound ...

Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor–Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial Our findings revealed a ...

By examining genomic variation more closely, scientists can now identify new disease connections with greater speed and accuracy. For centuries, scientists have recognized that certain illnesses can ...

With a closer look at genomic variation, scientists now have a faster, more precise way to uncover new links to disease EMBL ...

What happens when you squeeze DNA? Can pressure reveal something about how our genetic material is packed, protected, and ...

Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II/III Trial NRG-CC003 We integrated data from five prospective studies of ...